Publication | Open Access
Increased activity of colistin in combination with amikacin against Escherichia coli co-producing NDM-5 and MCR-1
47
Citations
29
References
2017
Year
The combination of colistin and amikacin may be a promising therapeutic option for the treatment of lethal infections caused by NDM-5-bearing MCR-1-positive superbugs.
| Year | Citations | |
|---|---|---|
Page 1
Page 1